Study Finds Hormone Therapy Helpful For Cystic Fibrosis

HGH helpful for Cystic Fibrosis

By William Weir,

Human growth hormone is a promising tool in treating cystic fibrosis, a new University of Connecticut study suggests.

Although HGH not a cure for the disease, which afflicts 30,000 people in the U.S., the researchers found that it reduced the number of hospitalizations among those who have the disease.

The study, published Monday in the journal Pediatrics, was produced by the UConn/Hartford Hospital Evidence-based Practice Center and was funded by the U.S. Department of Health and Human Services. Continue reading

Students organize Crohn’s Growth Foundation

Using HGH to fight Crohn’s Disease

By Chase Wade, Features Intern,

What started as a conversation between SMU juniors Sam Aronowitz and Stephen Poulin became a new foundation looking to change the way SMU views Crohn’s disease.

Both Aronowitz and Poulin have family members with the disease. Aronowitz said these family members are the ones who motivated them to start the Crohn’s Growth Foundation.

Considered a genetic disease by some medical professionals, Crohn’s disease involves the inflammation of the small and large intestines, resulting in side effects such as stomach-ache, diarrhea, fatigue, malnutrition and stunted growth in children. Continue reading

Human growth hormone shows promise in treating cystic fibrosis symptoms

By Colin Poitras

Human growth hormone can be used successfully to treat some symptoms of cystic fibrosis and prevent hospitalizations, but its impact on the disease itself remains unknown, according to a new report produced by the University of Connecticut/Hartford Hospital Evidence-based Practice Center.

Cystic fibrosis is an inherited, chronic, multi-organ disease caused by a defective gene, in which the body produces thick mucus that clogs the lungs and leads to life-threatening lung infections. The disease also makes it difficult for the pancreas to work, hampering the ability to absorb food. Common signs are salty tasting skin, difficulty breathing, chronic lung infections, poor weight gain, and shorter height. Typically detected in childhood, the disease stunts the patient’s growth and usually leads to early death. Continue reading